Bats Global Markets — Merger or Acquisition (November 2016)
35 slides from Bats Global Markets's merger presentation, Nov 10, 2016

Slide 1: Forward-Looking Statements
Forward-Looking Statements Cautionary Statements Regarding Forward-Looking Information This presentation contains certain statements regarding intentions, beliefs and expectations or predictions for the future of CBOE Holdings, Inc. (“CBOE”) and Bats Global Markets, Inc. (“Bats”), which are forward-

Slide 2: Additional Information
Additional Information Additional Information Regarding the Transaction and Where to Find It This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This presentation is being made in respect of the propo

Slide 3: Key Events in Roadmap to Completion
Key Events in Roadmap to Completion File registration statement and joint proxy statement with SEC CBOE and Bats shareholder votes Regulatory clearances, approvals and notifications Transaction expected to close during first half of 2017 Expand and diversify CBOE’s product line across new asset clas

Slide 4: CBOE's Strategic Initiatives
CBOE’s Strategic Initiatives Transaction Aligns with Strategy Develop unique products Strengthens CBOE’s global position in innovative, tradable products and services Expand our customer base Broadens geographic reach and enables company to build on relationships with market participants Form strate

Slide 5: Solid Third-Quarter Results; Difficult Comparison to 3Q15
Trading in our proprietary index suite up 5% YTD¹ 3Q16 adjusted EPS of $0.58 on revenue of $156 million ADV for CBOE’s index suite up 4% YTD¹, led by 15% increase in VIX futures ADV for multiply-listed options traded industrywide down 4% YTD¹ Solid Third-Quarter Results; Difficult Comparison to 3Q15

Slide 6: Further Developing Current Products to Grow Index Product Line
Further Developing Current Products to Grow Index Product Line S&P 500® Index (SPX) options, the most actively traded U.S. index option SPX ADV up 4% YoY through October Introduced SPX Weeklys with Wednesday Expirations on Feb. 23 Increases opportunities to trade SPX Wednesday expirations averaging

Slide 7: Leveraging VIX Methodology to Create New Products
Leveraging VIX® Methodology to Create New Products and Grow Index Product Line CBOE Volatility Index® (VIX Index) is considered the world’s barometer of equity market volatility VIX futures ADV up 15% YoY through October VIX options ADV unchanged YoY through October Began overnight dissemination of

Slide 8: Broadening Access to Proprietary Products
Over 11% of VIX futures traded during non-U.S. hours through October 2016, up from 9% for full-year 2015 Broadening Access to Proprietary Products ¹Extended hours to nearly 24X5 on June 22, 2014 *Hours in Central Time Zone Generally, on days when volatility spikes, overnight volume increases and acc

Slide 9: Product Development Remains Key to our Value Proposition
Product Development Remains Key to our Value Proposition Product innovation is central to our value proposition and enables CBOE to offer the world’s widest array of options and volatility products Launched CBOE S&P 500 Smile Index in October A premium-capture strategy benchmark index Constructed to

Slide 10: Expanding Options and Volatility Trading
CBOE Vest Financial launched two new mutual funds CBOE Vest S&P 500 Buffer Protect Strategy Fund First mutual fund designed to provide investors with index-based buffer protection Designed to provide a risk-managed investment that seeks to protect against some downside losses in the S&P 500 index, w

Slide 11: Leveraging Partnerships With Index Providers
Expanding global customer base through joint trading and educational services with our index provider partners In 2015, launched options on MSCI EAFE Index and MSCI Emerging Markets Index Following concentrated business development efforts, begun to see growing traction in MSCI trading Plan to broad

Slide 12: Expanding Our Global Customer Base
Fifth annual CBOE Risk Management Conference (RMC) Europe took place Sept. 26 through 28 in Ireland Second RMC Asia to take place in Hong Kong Begins on November 30th 33rd annual CBOE RMC U.S. planned to take place in California on March 8-10, 2017 Expanding Our Global Customer Base Initiatives focu

Slide 13: Forming Alliances that Leverage Our Strengths: CurveGlobal
Teamed with London Stock Exchange Group (LSEG) and major dealer banks to form CurveGlobal, a new interest rate derivatives platform Launched on September 26th Products trade on the LSE Derivatives Market and clear through LCH.Clearnet Expected to provide more product choices, increased trading effic

Slide 14: Forming Alliances that Leverage Our Strengths: Eris
CBOE made a minority equity investment in Eris Exchange Holdings, LLC (Eris) in May Eris is a U.S.-based futures exchange group offering swap futures as a capital-efficient alternative to over-the-counter (OTC) swaps CBOE and Eris partnership will focus on: Developing new proprietary products and in

Slide 15: Enhancing Shareholder Value
Enhancing Shareholder Value ’11 - ’15 CAGR 5% Strong cash flow generation and disciplined approach to managing cash Cash of $73 million at Sept. 30, 2016 Generated $174 million in operating cash flow YTD¹ Capital outlays YTD¹: $36 million for capital expenditures $58 million to pay dividends $65 mil

Slide 16: Committed to Returning Capital to Shareholders
Expect to maintain a strong balance sheet and flexibility for: Capital expenditures Dividend payments Opportunistic share repurchases Other strategic initiatives Committed to Returning Capital to Shareholders ¹TD through September 30, 2016 $47 $50 $45 $168 $132 $60 2011 2012 2013 2014 2015 2016 TD¹

Slide 17: Committed to Returning Capital to Shareholders
[e=.9 HOLDINGS Committed to Returning Capital to Shareholders > Expect to maintain a strong balance sheet and flexibility for: e Capital expenditures e Dividend payments e Opportunistic share repurchases e Other strategic initiatives Cash Used Under Share Repurchase Plan Change in Quarterly Dividend

Slide 18: 2016 Full-Year Guidance
2016 Full-Year Guidance As of October 28, 20161 ($ in millions) Full-Year Guidance as of July 29, 2016 Updated Guidance as of October 28, 2016 Core operating expenses $211 to $215 Expect to be slightly below range of $211 to $215 Continuing stock-based compensation² $13.5 $13.5 Accelerated stock-bas

Slide 19: Solid YTD Results Reflect Commitment to Strategic Initiatives
Solid YTD Results Reflect Companywide Commitment to Executing our Strategic Initiatives ¹TD through September 30, 2016 ²Adjusted to reflect the impact of certain items. See appendix for “Non-GAAP Information.” $508 $512 $572 $617 $633 $479 $482 2011 2012 2013 2014 2015 2015 TD¹ 2016 TD¹ Adjusted Ope

Slide 20: Optimistic About Long-Term Growth Prospects
¹Adjusted to reflect the impact of certain items. See Appendix for “Non-GAAP Information.” Optimistic About Long-Term Growth Prospects $0.20 $0.25 $0.30 $0.35 $0.40 $0.45 $0.50 $0.55 $0.60 $0.65 $0.70 $0.75 $0.80 $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q1

Slide 21: 2016 Financial Overview
2016 Financial Overview (in millions, except EPS and RPC) 9 mos. Ended 09/30/16 9 mos. Ended 09/30/15 $ Change % Change Operating Revenue $481.9 $478.6 $3.3 1% Adjusted Operating Expenses¹ 247.0 234.6 12.4 5% Adjusted Operating Income¹ $234.9 $244.0 -$9.1 -4% Adjusted Operating Margin %¹ 48.7% 51.0%

Slide 22: Proprietary Products Account for Growing Percentage of Transaction Fee Revenue
Proprietary Products Account for Growing Percentage of Transaction Fee Revenue Index options and futures contracts account for 87.9% of transaction fees through Sept. ‘16, up from 50.6% in 2010 ¹YTD Through September 30, 2016 2.3% 4.6% 10.5% 15.9% 18.8% 19.2% 21.9% 48.3% 52.9% 57.2% 62.9% 63.0% 63.7

Slide 23: Proprietary Products Account for Growing Percentage of Transaction Fee Revenue
Proprietary Products Account for Growing Percentage of Transaction Fee Revenue Index options and futures contracts accounted for 90.0% of transaction fees in 3Q16 versus 84.0% in 3Q15 and 87.9% in 2Q16 19.0% 18.3% 18.4% 23.6% 23.8% 65.0% 64.8% 67.4% 64.3% 66.2% 9.0% 8.9% 7.8% 6.9% 5.8% 7.0% 8.0% 6.4

Slide 24: RPC Variance Reflects Shift in Product Mix and Volume Discounts
RPC Variance Primarily Reflects Shift in Product Mix and Higher Volume-related Discounts Trading Volume Mix & RPC 3Q15 vs 3Q16 Equity 31.9% ETPs 27.4% Futures 5.3% S&P Indexes 21.9% VIX 11.9% Other 1.6% Index 35.4% 3Q16 Trading Volume Mix $1.647 $0.368 $0.709 $0.143 $0.106 3Q15 RPC $0.431 $1.709 $0.

Slide 25: Quarterly Options ADV
CBOE and C2 Quarterly Options ADV (in millions) Quarterly Options ADV ¹TD through October 31, 2016 1.60 1.60 1.77 1.91 2.17 1.81 1.85 1.94 1.81 1.53 1.48 1.43 1.45 1.36 1.48 1.45 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 TD¹ Equity Options (in millions) 1.11 1.6

Slide 26: CBOE Holdings Rolling 3-Month RPC
CBOE Holdings Rolling 3-Month RPC 2016 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Equities $0.095 $0.092 $0.085 $0.081 $0.075 $0.070 $0.063 $0.057 $0.050 Exchange-traded products 0.138 0.131 0.117 0.111 0.104 0.103 0.096 0.089 0.079 Indexes 0.738 0.733 0.720 0.706 0.698 0.701 0.704 0.706 0.707

Slide 27: Quarterly Core Operating Expenses
Quarterly Core Operating Expenses¹ ($ in thousands) 3Q 2016 % rev 2Q 2016 % rev 1Q 2016 % rev 4Q 2015 % rev 3Q 2015 % rev 2Q 2015 % rev 1Q 2015 % rev 4Q 2014 % rev 3Q 2014 % rev 2Q 2014 % rev 1Q 2014 % rev 4Q 2013 % rev 3Q 2013 % rev 2Q 2013 % rev 1Q 2013 % rev 4Q 2012 % rev 3Q 2012 % rev 2Q 2012 %

Slide 28: Annual Core Operating Expenses
Annual Core Operating Expenses¹ ($ in thousands) 2016 YTD % rev 2015 % rev 2014 % rev 2013 % rev 2012 % rev 2011 % rev 2010 % rev 2009 % rev 2008 % rev Total Operating Expenses $258,768 54% $314,617 50% $303,424 49% $286,236 50% $268,241 52% $266,512 52% $269,763 62% $248,497 62% $229,473 55% Less:

Slide 29: GAAP to Non-GAAP Reconciliation For 2010 and 2011
GAAP to Non-GAAP Reconciliation For 2010 and 2011 GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 FY2010 FY2011 GAAP net incom e allocated to com m on s tockholders $

Slide 30: GAAP to Non-GAAP Reconciliation For 2012 and 2013
GAAP to Non-GAAP Reconciliation For 2012 and 2013 GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) 1Q12 2Q12 3Q12 4Q12 FY2012 1Q13 2Q13 3Q13 4Q13 FY2013 Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP GAAP net income allocated to common stockhold

Slide 31: GAAP to Non-GAAP Reconciliation For 2014 and 2015
GAAP to Non-GAAP Reconciliation For 2014 and 2015 GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) 1Q14 2Q14 3Q14 4Q14 FY2014 1Q15 2Q15 3Q15 4Q15 FY2015 Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP GAAP net income allocated to common stockhold

Slide 32: GAAP to Non-GAAP Reconciliation For 2016
GAAP to Non-GAAP Reconciliation For 2016 (in thousands, except per share amounts) Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP 1Q16 2Q16 3Q16 4Q16 FY2016 GAAP net income allocated to common stockholders $ 49,198 $ 50,719 $ 40,280 $ 139,974 Add: Compensation and benef

Slide 33: Non-GAAP Information
In addition to disclosing results determined in accordance with GAAP, CBOE Holdings has disclosed certain non-GAAP measures of operating performance. These measures are not in accordance with, or a substitute for, GAAP, and may be different from or inconsistent with non-GAAP financial measures used

Slide 34: CBOE contact address
CBOE 400 South LaSalle Street Chicago, Illinois 60605 www.cboe.com

Slide 35: CBOE contact address
CBOE 400 South LaSalle Street Chicago, Illinois 60605
Source: SEC EDGAR · 425 filed Nov 10, 2016
More decks from Bats Global Markets Inc
Q4 2016 Earnings Presentation25 slides · Feb 9, 2017
Q4 2016 Earnings Presentation43 slides · Feb 6, 2017
Merger or Acquisition (February 2017)7 slides · Feb 1, 2017
Merger or Acquisition (January 2017)7 slides · Jan 18, 2017
Merger or Acquisition (January 2017)21 slides · Jan 3, 2017
Merger or Acquisition (December 2016)7 slides · Dec 22, 2016